Qiliqiangxin capsule attenuates platelet activation and thrombosis by suppressing Ca2+ influx and PKC signaling
Abstract Background Arterial thrombotic diseases are leading causes of global morbidity and mortality, primarily driven by platelet hyperactivity. Qiliqiangxin capsules (QLQX), a traditional Chinese medicine approved in China for the treatment of heart failure, have exhibited potential benefits in r...
Salvato in:
| Autori principali: | , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2026-01-01
|
| Serie: | Thrombosis Journal |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1186/s12959-025-00823-8 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|